1 BTC
=
- USD
IM Cannabis Corp. Common Shares
As of May 30, 2026 at 24:05 UTC
Chart
About IM Cannabis Corp. Common Shares
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
Market Statistics
Trading Metrics
How to Buy IMCC
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy IMCC
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesIM Cannabis Corp. (NASDAQ: IMCC) reported Q1 2026 results with revenues of $8.7 million, gross profit of $1.4 million, and a net loss of $2.5 million ($0.38 per share). The company reduced general and administrative expenses by 22% year-over-year and completed convertible note financings to support liquidity management. Operations continue in Israel and Germany with focus on cost optimization and strategic opportunities.
IM Cannabis Corp (NASDAQ: IMCC) announced the closing of convertible note financings totaling US$550,000 in gross proceeds. The company issued two convertible notes with warrants to institutional investors, with net proceeds to be used for general corporate purposes. The notes feature conversion prices tied to market conditions and include standard protective provisions for investors.
IM Cannabis Corp. reported 2025 full-year revenue of C$54.7 million with strong 134% growth in Germany, now representing 66% of total revenue. The company achieved positive operating cash flow of C$4.7 million, a significant turnaround from 2024, and strengthened its cash position to C$3.3 million through strategic financings. Additionally, IMC announced plans to diversify into defense technology through a proposed acquisition of 51% stake in Polish company Black Axe Technologies.
IM Cannabis Corp. (NASDAQ:IMCC) announced it has raised US$2.17 million through two note purchase agreements with a third-party lender to manage liquidity requirements. The First Note of US$1.54 million and Second Note of US$632,911.50 both carry 8% interest (increasing to 14% upon default) with 18-month maturities and conversion options. Approximately US$1 million of proceeds were used to repay existing creditors, with remaining funds allocated to working capital and strategic initiatives.
IM Cannabis Corp. announced board changes, with two directors resigning and two new directors appointed. Oz Adler was named Board Chairman, and the company plans to explore additional business opportunities to enhance long-term growth.